Evaluation of liver fibrosis in patients with Wilson's disease

Eur J Gastroenterol Hepatol. 2021 Apr 1;33(4):535-540. doi: 10.1097/MEG.0000000000001754.

Abstract

Objectives: Staging of fibrosis in chronic liver disease is important for prognosis and treatment planning. Liver biopsy is the gold standard in fibrosis assessment; however, new methods for fibrosis and stiffness measurement exist which have not been evaluated in patients with Wilson's disease. To evaluate the accuracy of collagen proportionate area (CPA), transient elastography and shear wave elastography (SWE) in the assessment of liver fibrosis in adult patients with Wilson's disease.

Methods: In this retrospective study of 60 patients with Wilson's disease, results of percutaneous cutting liver biopsy assessed using the Ishak fibrosis score and CPA were compared with liver stiffness measured with transient elastography and SWE.

Results: CPA correlated with the Ishak score (r = 0.45; P = 0.001) and transient elastography results correlated with SWE measurements (r = 0.80; P = 0.0001). In contrast, transient elastography or SWE did not significantly correlate with the Ishak score or CPA.

Conclusion: Collagen content assessment may be useful for estimation of liver fibrosis in patients with Wilson's disease. However, single time-point elastographic liver stiffness measurements have a limited diagnostic value in Wilson's disease.

MeSH terms

  • Adult
  • Biopsy
  • Elasticity Imaging Techniques*
  • Hepatolenticular Degeneration* / diagnostic imaging
  • Humans
  • Liver / diagnostic imaging
  • Liver Cirrhosis / diagnostic imaging
  • Retrospective Studies